Discontinued — last reported Q4 '19

Other

Loans collectively evaluated for impairment - associated allowance

Fifth Third Bank Loans collectively evaluated for impairment - associated allowance increased by 34.0% to $2.76B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.0%, from $2.19B to $2.76B. Over 5 years (FY 2020 to FY 2025), Loans collectively evaluated for impairment - associated allowance shows relatively stable performance with a -1.6% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2013
Last reportedQ4 2019
Metric ID: other_financing_receivable_allowance_for_credit_losses_c_414c67

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.84B$1.77B$1.73B$1.74B$1.85B$1.94B$2.07B$2.14B$2.20B$2.26B$2.23B$2.19B$2.20B$2.21B$2.24B$2.19B$2.22B$2.10B$2.06B$2.76B
QoQ Change-3.6%-2.5%+0.4%+6.8%+4.8%+6.7%+3.0%+3.2%+2.7%-1.6%-1.4%+0.0%+0.5%+1.3%-1.9%+1.1%-5.5%-1.7%+34.0%
YoY Change+0.8%+9.5%+19.9%+23.1%+18.9%+16.5%+7.4%+2.8%-0.4%-2.5%+0.4%-0.1%+1.0%-5.1%-7.8%+26.0%
Range$1.73B$2.76B
CAGR+8.9%
Avg YoY Growth+6.9%
Median YoY Growth+1.9%

Loans collectively evaluated for impairment - associated allowance at Other Companies

Frequently Asked Questions

What is Fifth Third Bank's loans collectively evaluated for impairment - associated allowance?
Fifth Third Bank (FITB) reported loans collectively evaluated for impairment - associated allowance of $2.76B in Q1 2026.
How has Fifth Third Bank's loans collectively evaluated for impairment - associated allowance changed year-over-year?
Fifth Third Bank's loans collectively evaluated for impairment - associated allowance increased by 26.0% year-over-year, from $2.19B to $2.76B.
What is the long-term trend for Fifth Third Bank's loans collectively evaluated for impairment - associated allowance?
Over 5 years (2020 to 2025), Fifth Third Bank's loans collectively evaluated for impairment - associated allowance has grown at a -1.6% compound annual growth rate (CAGR), from $2.23B to $2.06B.